Go Pro

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$119.68 +0.90 (+0.76%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$119.58 -0.10 (-0.08%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADUS vs. PACS, HIMS, BLLN, SHC, and RDNT

Should you buy Addus HomeCare stock or one of its competitors? MarketBeat compares Addus HomeCare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Addus HomeCare include PACS Group (PACS), Hims & Hers Health (HIMS), Billiontoone (BLLN), Sotera Health (SHC), and RadNet (RDNT).

How does Addus HomeCare compare to PACS Group?

Addus HomeCare (NASDAQ:ADUS) and PACS Group (NYSE:PACS) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

In the previous week, PACS Group had 4 more articles in the media than Addus HomeCare. MarketBeat recorded 21 mentions for PACS Group and 17 mentions for Addus HomeCare. PACS Group's average media sentiment score of 0.87 beat Addus HomeCare's score of 0.68 indicating that PACS Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
6 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Addus HomeCare has a net margin of 7.13% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare7.13% 9.96% 7.62%
PACS Group 4.85%29.55%5.23%

Addus HomeCare presently has a consensus price target of $130.88, suggesting a potential upside of 9.35%. PACS Group has a consensus price target of $54.20, suggesting a potential upside of 12.04%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

PACS Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.57$95.91M$5.7021.00
PACS Group$5.29B1.45$191.54M$1.7228.13

Addus HomeCare has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market.

Summary

Addus HomeCare beats PACS Group on 9 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Hims & Hers Health?

Addus HomeCare (NASDAQ:ADUS) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Addus HomeCare currently has a consensus target price of $130.88, indicating a potential upside of 9.35%. Hims & Hers Health has a consensus target price of $31.43, indicating a potential downside of 0.46%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19

Addus HomeCare has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, suggesting that its stock price is 140% more volatile than the broader market.

Addus HomeCare has a net margin of 7.13% compared to Hims & Hers Health's net margin of -0.56%. Addus HomeCare's return on equity of 9.96% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare7.13% 9.96% 7.62%
Hims & Hers Health -0.56%6.10%1.52%

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.57$95.91M$5.7021.00
Hims & Hers Health$2.35B3.11$128.37M-$0.09N/A

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 4 more articles in the media than Addus HomeCare. MarketBeat recorded 21 mentions for Hims & Hers Health and 17 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Hims & Hers Health's score of 0.39 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
4 Very Positive mention(s)
2 Positive mention(s)
14 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Addus HomeCare beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

95.4% of Addus HomeCare shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Billiontoone presently has a consensus price target of $126.71, indicating a potential upside of 35.68%. Addus HomeCare has a consensus price target of $130.88, indicating a potential upside of 9.35%. Given Billiontoone's higher probable upside, equities analysts plainly believe Billiontoone is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73

In the previous week, Billiontoone had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 29 mentions for Billiontoone and 17 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Billiontoone's score of 0.16 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
9 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$397.41M10.81$7.45M$0.70133.41
Addus HomeCare$1.42B1.57$95.91M$5.7021.00

Billiontoone has a net margin of 8.04% compared to Addus HomeCare's net margin of 7.13%.

Company Net Margins Return on Equity Return on Assets
Billiontoone8.04% 9.96% 5.35%
Addus HomeCare 7.13%9.96%7.62%

Summary

Addus HomeCare beats Billiontoone on 9 of the 15 factors compared between the two stocks.

How does Addus HomeCare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, media sentiment and valuation.

Addus HomeCare has higher revenue and earnings than Sotera Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B4.62$77.94M$0.4146.00
Addus HomeCare$1.42B1.57$95.91M$5.7021.00

Sotera Health presently has a consensus price target of $21.50, suggesting a potential upside of 14.00%. Addus HomeCare has a consensus price target of $130.88, suggesting a potential upside of 9.35%. Given Sotera Health's higher probable upside, equities research analysts plainly believe Sotera Health is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73

In the previous week, Sotera Health and Sotera Health both had 17 articles in the media. Sotera Health's average media sentiment score of 0.97 beat Addus HomeCare's score of 0.68 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
7 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sotera Health has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Sotera Health has a net margin of 13.44% compared to Addus HomeCare's net margin of 7.13%. Sotera Health's return on equity of 40.12% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health13.44% 40.12% 7.55%
Addus HomeCare 7.13%9.96%7.62%

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Sotera Health beats Addus HomeCare on 9 of the 15 factors compared between the two stocks.

How does Addus HomeCare compare to RadNet?

Addus HomeCare (NASDAQ:ADUS) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

In the previous week, Addus HomeCare had 12 more articles in the media than RadNet. MarketBeat recorded 17 mentions for Addus HomeCare and 5 mentions for RadNet. RadNet's average media sentiment score of 1.15 beat Addus HomeCare's score of 0.68 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare currently has a consensus price target of $130.88, suggesting a potential upside of 9.35%. RadNet has a consensus price target of $87.43, suggesting a potential upside of 20.77%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80

Addus HomeCare has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.57$95.91M$5.7021.00
RadNet$2.04B2.79-$18.65M-$0.18N/A

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Comparatively, 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.66%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare7.13% 9.96% 7.62%
RadNet -0.66%2.77%0.97%

Summary

Addus HomeCare beats RadNet on 9 of the 17 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.22B$9.83B$6.93B$12.86B
Dividend YieldN/A2.54%2.59%9.91%
P/E Ratio21.0029.19270.2825.05
Price / Sales1.574.81597.3999.22
Price / Cash18.29127.7771.4649.72
Price / Book1.955.3713.256.21
Net Income$95.91M$309.96M$3.45B$342.45M
7 Day Performance3.64%1.78%4.65%4.41%
1 Month Performance12.57%0.65%-0.79%-0.28%
1 Year Performance8.61%22.96%77.75%22.60%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
3.1363 of 5 stars
$119.68
+0.8%
$130.88
+9.4%
+9.7%$2.22B$1.42B21.0050,659
PACS
PACS Group
3.6899 of 5 stars
$46.38
-1.5%
$50.60
+9.1%
+336.4%$7.35B$5.43B29.7847,455
HIMS
Hims & Hers Health
2.081 of 5 stars
$27.97
-7.5%
$31.43
+12.4%
-38.1%$6.48B$2.37BN/A2,442
BLLN
Billiontoone
4.2915 of 5 stars
$126.42
-1.2%
$126.00
-0.3%
N/A$5.81B$305.11M229.50620
SHC
Sotera Health
4.0815 of 5 stars
$17.41
+1.0%
$20.25
+16.3%
+68.1%$4.97B$1.19B42.553,000

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 8/8/2026 by MarketBeat.com Staff.
From Our Partners